【24h】

Ethics in biomonitoring for occupational health

机译:职业健康生物监测中的伦理

获取原文
获取原文并翻译 | 示例
           

摘要

Biological monitoring, i.e., the use of biomarkers for the measurement of systemic human exposure, effects and susceptibility to chemicals has increased considerably in recent years. Biomonitoring techniques, originally limited to a few metals and other chemicals in the workplace, are currently applied to a large number of exposure situations and have become a useful tool for occupational and environmental health risk assessment. Almost any biomonitoring program, however, entails a number of relevant ethical issues, which concern all the phases of the entire process, from the selection of the biomarker to the study design, from the collection, storage and analysis of the biological sample to the interpretation, communication and management of the results, from the (truly?) informed consent of the worker to the independence and autonomy of the occupational health professional. These issues require a balanced assessment of the interests and responsibilities of all the parties, the worker primarily, but also the employer, the occupational health professional, the health authorities and, for research studies on new biomarkers, also the scientists involved. Ideally, decisions of ethical relevance concerning biomarkers should be based on, and respectful of the best scientific, legal and ethical evidence available. When, however, a conflict should arise, before any decision is taken a thorough risk-benefit analysis should be done, at the beginning of the process and after listening to the workers and the management involved, by the occupational physician or scientist, based on his/her professional experience, independent judgement and individual responsibility. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
机译:近年来,生物监测,即使用生物标志物来测量人体的全身暴露,对化学品的影响和易感性已大大增加。生物监测技术最初仅限于工作场所中的几种金属和其他化学物质,目前已应用于大量接触情况,并已成为评估职业和环境健康风险的有用工具。但是,几乎任何生物监测程序都涉及许多相关的伦理问题,这些问题涉及整个过程的所有阶段,从生物标记的选择到研究设计,从生物样品的收集,存储和分析到解释的整个过程。 ,对结果的沟通和管理,从工人的(真正的?)知情同意到职业健康专业人员的独立性和自主性。这些问题需要对各方(主要是工人),雇主,职业健康专业人员,卫生当局以及对于新生物标志物的研究也要涉及的科学家的利益和责任进行平衡的评估。理想情况下,有关生物标志物的伦理相关性决定应基于并尊重现有的最佳科学,法律和伦理证据。但是,当发生冲突时,在做出任何决定之前,应在过程开始时以及在职业医师或科学家根据以下情况进行彻底的风险收益分析之前,由职业医师或科学家进行调查:他/她的专业经验,独立判断和个人责任感。 (C)2014 Elsevier Ireland Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号